5+ hour, 18+ min ago  (133+ words) Cristina Oprean, Chief of the Oncology Day Hospital at Asociatia Oncohelp, shared on'LinkedIn: "Last week on Thursday I had a day full of positive emotions and gratitude! I have the final talk about my Doctoral Thesis on the topic "Clinical…...

12+ hour, 40+ min ago  (63+ words) Nabil Ismaili, Director of Medical Oncology and Radiotherapy Department at Mohammed VI University of Sciences and Health , shared a post on LinkedIn: "Game-changing algorithms for early HR+ breast cancer in 2025!" Title: A Systematic Review of Major Advances in Breast Cancer…...

14+ hour, 5+ min ago  (360+ words) Pedro Lopez, Honorary Senior Research Fellow at the Institute for Respiratory Health, Associate Professor at the University of Caxias do Sul, and Adjunct Lecturer at Edith Cowan University, shared a post on LinkedIn: "New Research Alert: Do Combined Exercise Programs…...

15+ hour, 26+ min ago  (143+ words) Reach to Recovery International: Abstract Submissions Open for 20th Breast Cancer Support Conference'Oncodaily Reach to Recovery International: Abstract Submissions Open for 20th Breast Cancer Support Conference The 20th Reach to Recovery International Breast Cancer Support Conference will take place from June 2628, 2026, at Sunway…...

20+ hour, 54+ min ago  (529+ words) For years, hormone receptor'positive (HR+) metastatic breast cancer was described as "indolent." It was slower than triple-negative disease. It was more responsive to endocrine therapy. But resistance was inevitable. Median overall survival rarely crossed four years in metastatic settings. Treatment…...

1+ week, 1+ day ago  (137+ words) What an incredible start to our 1st Edition of Post-Graduation Cource in Breast Diseases The first two days have exceeded all expectations. Our expert speakers (In's Moruj'o, Rita Sampaio, Margarida Brito and Fernando Os'rio) have delivered profound insights, challenging perspectives and…...

2+ week, 1+ day ago  (117+ words) OncoDaily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments…...

2+ week, 1+ day ago  (101+ words) Naoto T Ueno, Director of the University of Hawaii Cancer Center, shared a post on'X: "Tumors resistant to one ADC can regain sensitivity to another ADC with a different payload. Our work shows payload choice-not just target expression-may extend clinical…...

2+ week, 3+ day ago  (109+ words) 14th Asia-Pacific Breast Cancer Summit 2026shared a post onLinkedIn: "We are honored to welcome Dr. Najihah Binti Abu Bakar as part of our Local Faculty at the Asia-Pacific Breast Cancer Summit 2026. Dr. Najihah is a Clinical Oncologist at Hospital Kuala Lumpur (HKL)....

2+ week, 3+ day ago  (184+ words) Susheel Kumar Yeshala, Consultant Medical Oncologist at American Oncology Institute, shared a post on'LinkedIn: "A wonderful evening of learning and reflection on HR+/HER2-negative breast cancer. -HR+/HER2-negative breast cancer is a molecular umbrella, not a single disease. -Includes luminal…...